XSUS:CA:TSX-iShares ESG MSCI USA Index (CAD)

ETF | US Equity |

Last Closing

CAD 40.96

Change

+0.20 (+0.49)%

Market Cap

CAD 0.58B

Volume

546.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-07 )

Largest Industry Peers for US Equity

Symbol Name Price(Change) Market Cap
VFV:CA Vanguard S&P 500 Index ETF

+1.28 (+0.93%)

CAD 21.09B
ZSP:CA BMO S&P 500

+0.74 (+0.88%)

CAD 17.10B
XSP:CA iShares Core S&P 500 (CAD Hedg..

+0.30 (+0.52%)

CAD 11.46B
VUN:CA Vanguard US Total Market

+0.90 (+0.87%)

CAD 10.87B
XUS:CA iShares Core S&P 500 Index ETF

+0.42 (+0.88%)

CAD 8.70B
HXS:CA Global X S&P 500 Corporate Cla..

+0.70 (+0.88%)

CAD 4.34B
VSP:CA Vanguard S&P 500 CAD hedged

+0.40 (+0.44%)

CAD 4.04B
QUU:CA Mackenzie US Large Cap Equity ..

+1.49 (+0.67%)

CAD 3.60B
XUU:CA iShares Core S&P US Total Mark..

+0.42 (+0.74%)

CAD 3.34B
ZUE:CA BMO S&P 500 (CAD Hedged)

+0.39 (+0.51%)

CAD 3.23B

ETFs Containing XSUS:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (US Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -8.80% 9% A- 19% F
Dividend Return 0.20% 17% F 5% F
Total Return -8.60% 9% A- 19% F
Trailing 12 Months  
Capital Gain 8.47% 66% D+ 66% D+
Dividend Return 1.01% 27% F 18% F
Total Return 9.49% 66% D+ 59% D-
Trailing 5 Years  
Capital Gain 85.17% 72% C 75% C
Dividend Return 7.18% 21% F 10% F
Total Return 92.35% 68% D+ 70% C-
Average Annual (5 Year Horizon)  
Capital Gain 14.27% 76% C+ 80% B-
Dividend Return 15.20% 74% C 78% C+
Total Return 0.93% 35% F 36% F
Risk Return Profile  
Volatility (Standard Deviation) 15.04% 38% F 54% F
Risk Adjusted Return 101.06% 60% D- 93% A
Market Capitalization 0.58B 53% F 62% D

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.